Iloprost in combination therapies for the treatment of...

A - Human Necessities – 61 – P

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61P 9/12 (2006.01) A61K 31/192 (2006.01) A61K 31/422 (2006.01) A61K 31/506 (2006.01) A61K 31/513 (2006.01) A61K 31/5575 (2006.01) A61K 45/06 (2006.01)

Patent

CA 2539512

Preferred embodiments of the present invention are related to novel therapeutic drug combinations and methods for treating pulmonary arterial hypertension. More particularly, aspects of the present invention are related to using a combination of iloprost and at least one additional agent, selected from the group consisting of an endothelin receptor antagonist and a PDE inhibitor.

Des modes de réalisation préférés de l'invention concernent de nouvelles combinaisons de médicaments thérapeutiques et des méthodes de traitement de l'hypertension artérielle pulmonaire. En particulier, certains aspects de l'invention concernent l'utilisation d'une combinaison d'iloprost et d'au moins un agent supplémentaire, sélectionnés dans le groupe comprenant un antagoniste de récepteur de l'endothéline et un inhibiteur de PDE.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Iloprost in combination therapies for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Iloprost in combination therapies for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Iloprost in combination therapies for the treatment of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1489761

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.